ストックスクリーナーアプリを入手
25.21
0.80%
0.20
Pfizer Inc (PFE) 最新ニュース
Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns - Seeking Alpha
What Does the Market Think About Pfizer? - Benzinga
Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade) - Seeking Alpha
Minoxidil Market Set to Witness Significant Growth by 2025-2032 - openPR
Pfizer leader who launched Covid vaccine gives small pharma a try - The Business Journals
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History” - Markets Insider
UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection | Newswise - Newswise
Pfizer: Value Play Or Past Its Prime? - Barchart
Pfizer: Value Play or Past Its Prime? - The Globe and Mail
Pfizer Tops Pharma Tax Avoidance, Senate Dems Say - Law360
US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports - Reuters
Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator - Seeking Alpha
Sector Update: Health Care - Marketscreener.com
Pfizer's Bold Tax Maneuver Sparks Controversy - Finimize
Pfizer Avoided Billions in Taxes on Sales, Democrats Say (2) - Bloomberg Tax
Living with Colon Cancer: A Pfizer Colleague’s Story - Pfizer
May 9th Options Now Available For Pfizer (PFE) - Nasdaq
GSK accuses Pfizer of delaying Covid vaccine result until after US election - Yahoo
Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals? - Yahoo Finance
Why Pfizer Is My Largest Healthcare Position - MSN
Citi maintains Pfizer stock Neutral with $27 target amid probe By Investing.com - Investing.com Australia
Citi maintains Pfizer stock Neutral with $27 target amid probe - Investing.com
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report - New York Post
Exclusive | U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine - The Wall Street Journal
Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers - GuruFocus.com
Here's Why Pfizer (PFE) Fell More Than Broader Market - Yahoo Finance
Pfizer Shares Are Down Today: What's Going On? - Benzinga
Pfizer shares dip amid U.S. vaccine probe reports By Investing.com - Investing.com Australia
Pfizer shares dip amid U.S. vaccine probe reports - Investing.com
Pfizer drops after report on U.S. probe related to its COVID vaccine success - Seeking Alpha
Pfizer falls after report says US probing tip about timing of COVID vaccine - TradingView
US Prosecutors Investigate Tip on Pfizer Vaccine - Marketscreener.com
US Prosecutors Investigate Tip on Pfizer Vaccine, Wall Street Journal Reports - Marketscreener.com
US Prosecutors Probe Tip About Timing Of Pfizer VaccineWSJ - Marketscreener.com
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts By Investing.com - Investing.com South Africa
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com
Pfizer’s CX Vision: Powered by People, Fueled by Data - CMSWire
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program - Quantisnow
Pfizer Stock Slips After Report on Vaccine Timing Probe - The Wall Street Journal
Drug Co. Wants Fed. Circ. To Undo Pfizer COVID Patent Win - Law360
Pfizer: Undervalued Defensive Play - Yahoo Finance
Pfizer Is Trading As If It's 2009 Again (NYSE:PFE) - Seeking Alpha
Which is the Healthiest Investment: Merck or PfizerF.A.S.T. GraphsCommentaries - Advisor Perspectives
Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day - TradingView
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP
Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds? - Insider Monkey
Pfizer Is A Dirt-Cheap High-Yield Stock, But Is It A Buy? - Barchart
China touted its business potential at a meeting with Apple, Pfizer and other US companies - Українські Національні Новини
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy? - Zacks Investment Research
Pfizer Inc. (PFE) Stock: Is This Healthcare Giant the Bargain of 2025? - MoneyCheck
Epinephrine Market Is Booming Worldwide 2025-2032 | Pfizer, - openPR
0.57%
大文字化:
|
ボリューム (24 時間):